Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis.
Multiple sclerosis (MS) is a common inflammatory disease of the central nervous system unsurpassed for its variability in disease outcome. Given a possible role for dysregulation of iron metabolism in MS disease pathogenesis, we investigated whether or not mutations in the HFE gene influence the pro...
Main Authors: | Ramagopalan, S, Cukjati, M, Cernilec, M, DeLuca, G, Dyment, D, Degenhardt, A, Sadovnick, A, Serbec, VC, Ebers, G, Duquette, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2008
|
Similar Items
-
The genetics of clinical outcome in multiple sclerosis.
by: Ramagopalan, S, et al.
Published: (2008) -
No effect of APOE and PVRL2 on the clinical outcome of multiple sclerosis.
by: Ramagopalan, S, et al.
Published: (2007) -
The role of hereditary spastic paraplegia related genes in multiple sclerosis. A study of disease susceptibility and clinical outcome.
by: DeLuca, G, et al.
Published: (2007) -
Gestational diabetes and multiple sclerosis.
by: Ramagopalan, S, et al.
Published: (2009) -
Re: HLA-DRB1 and multiple sclerosis in Malta.
by: Ramagopalan, S, et al.
Published: (2008)